By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Generex Biotechnology Corporation 

33 Harbour Square
Suite 202
Toronto  Ontario  M5J 2G2  Canada
Phone: 416-364-2551 Fax: 416-364-9363


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Generex Biotechnology Corporation (GNBT) Announces Collaboration On Medicinal Cannabis 11/18/2014 2:31:06 PM
Generex Biotechnology Corporation (GNBT) Announces Presentation At The Society For Immunotherapy Of Cancer Demonstrating That Induction Of Antibody Response In Patients Receiving The AE37 Breast Cancer Vaccine Correlates With Reduced Relapse 11/11/2014 8:56:25 AM
Generex Biotechnology Corporation (GNBT) Announces Presentations Correlating Immunological Response With Reduced Recurrence In Phase 2 Study Of AE37 Breast Cancer Vaccine In Patients At The American College of Surgeons 10/27/2014 7:43:17 AM
Generex Biotechnology Corporation (GNBT) / Antigen Express, Inc. (GNBT) To Participate In 2014 Biotechnology Industry Organization (BIO)-Europe┬« Annual International Partnering Conference 10/23/2014 10:55:06 AM
Generex Biotechnology Corporation (GNBT) Announces Publication Of Ebola Vaccine White Paper By Antigen Express, Inc. (GNBT) 10/21/2014 9:30:53 AM
Generex Biotechnology Corporation (GNBT) Clarifies Utility Of Antigen Express Technology For Potential Ebola Vaccine 10/7/2014 9:43:37 AM
Generex Biotechnology Corporation (GNBT) Collaborates With University Health Network For Buccal Insulin Project 9/22/2014 8:12:49 AM
Generex Biotechnology Corporation (GNBT) / Antigen Express, Inc. (GNBT) To Participate In BioPharm America™ 2014 9/3/2014 9:09:38 AM
Generex Biotechnology Corporation (GNBT) Announces Publication Of AE37 Prostate Cancer Vaccine Study 8/6/2014 8:45:03 AM
Generex Biotechnology Corporation (GNBT) Announces Interview Of Dr. Eric Von Hofe, President Of Antigen Express, Inc. (GNBT), Following Recent Keynote Presentation 6/17/2014 10:27:43 AM
12345678910...
//-->